P3 Health Partners Inc. (NASDAQ:PIII – Get Free Report) major shareholder Pacific Founders Ugp I. Chicago acquired 80,000 shares of the firm’s stock in a transaction dated Wednesday, September 11th. The stock was bought at an average price of $0.56 per share, for a total transaction of $44,800.00. Following the completion of the acquisition, the insider now owns 77,025,438 shares in the company, valued at approximately $43,134,245.28. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
P3 Health Partners Trading Down 8.3 %
Shares of NASDAQ PIII opened at $0.50 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.69 and a quick ratio of 0.69. The business’s 50 day moving average is $0.55 and its two-hundred day moving average is $0.65. P3 Health Partners Inc. has a 52-week low of $0.40 and a 52-week high of $2.85.
P3 Health Partners (NASDAQ:PIII – Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.07). P3 Health Partners had a negative net margin of 4.95% and a negative return on equity of 43.19%. The firm had revenue of $379.16 million during the quarter, compared to analysts’ expectations of $364.50 million. As a group, equities research analysts predict that P3 Health Partners Inc. will post -0.23 EPS for the current fiscal year.
Institutional Inflows and Outflows
P3 Health Partners Company Profile
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
See Also
- Five stocks we like better than P3 Health Partners
- What Are Growth Stocks and Investing in Them
- 3 Fresh Stock Buybacks: These are the Ones to Buy
- Buy P&G Now, Before It Sets A New All-Time High
- Tesla’s New Buy Rating: Why Analysts Are Optimistic
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Is Halliburton Stock a Good Buy at Current Levels?
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.